Fresenius | FRE - Gross Profit On Sales

Stock Price
49.59
Daily Change
0.35 0.71%
Monthly
1.27%
Yearly
33.38%
Q1 Forecast
45.82

Fresenius reported EUR1.3B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.46B 70M Sep/2025
AstraZeneca USD 12.39B 406M Sep/2025
BASF EUR 3.16B 1.02B Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
DaVita Healthcare Partners USD 1.09B 144.19M Sep/2025
Demant DKK 8.82B 277M Dec/2025
E.ON EUR 4.63B 663M Sep/2025
Essilor EUR 8.84B 687M Jun/2025
Fresenius EUR 1.3B 158M Sep/2025
Fresenius Medical Care EUR 1.24B 27M Sep/2025
Getinge SEK 5.05B 1.5B Dec/2024
Givaudan CHF 823M 575M Jun/2024
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GN Store Nord DKK 2.5B 344M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.21B 186M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Philips EUR 1.91B 100M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
RWE EUR 723M 820M Sep/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025